CREA MEDIC: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CREA MEDIC
Largest movements
- Cash +€26,732
up €26,732 (+8.4%), from €318,232 to €344,965
mainly Net result for the year (+€156,935) and Other debts (+€74,661)
- Receivables within one year +€8,026
up €8,026 (+17.7%), from €45,220 to €53,246
of which Other amounts receivable: +€7,009
- Other debts +€74,661
up €74,661 (+25.4%), from €293,832 to €368,494
- Tax, wage and social debts -€39,025
down €39,025 (-62.4%), from €62,575 to €23,550
- Gross operating margin -€11,934
down €11,934 (-5.4%), from €222,141 to €210,207
- Taxes -€2,445
down €2,445 (-4.4%), from €55,435 to €52,991
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €368,638 | €403,237 | +€34,600 | +9.4% |
| Fixed assets | 21/28 | €169 | €0 | -€169 | -100% |
| Tangible fixed assets | 22/27 | €169 | €0 | -€169 | -100% |
| Furniture and vehicles | 24 | €169 | €0 | -€169 | -100% |
| Current assets | 29/58 | €368,469 | €403,237 | +€34,769 | +9.4% |
| Amounts receivable within one year | 40/41 | €45,220 | €53,246 | +€8,026 | +17.7% |
| Trade receivables | 40 | €45,220 | €46,237 | +€1,017 | +2.2% |
| Other amounts receivable | 41 | - | €7,009 | +€7,009 | |
| Cash at bank and in hand | 54/58 | €318,232 | €344,965 | +€26,732 | +8.4% |
| Deferred charges and accrued income | 490/1 | €5,017 | €5,027 | +€10 | +0.2% |
| Total equity and liabilities | 10/49 | €368,638 | €403,237 | +€34,600 | +9.4% |
| Equity | 10/15 | €10,902 | €10,837 | -€65 | -0.6% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €9,902 | €9,837 | -€65 | -0.7% |
| Amounts payable | 17/49 | €357,735 | €392,400 | +€34,665 | +9.7% |
| Amounts payable within one year | 42/48 | €357,735 | €392,400 | +€34,665 | +9.7% |
| Trade debts | 44 | €1,328 | €356 | -€972 | -73.2% |
| Suppliers | 440/4 | €1,328 | €356 | -€972 | -73.2% |
| Taxes, remuneration and social security | 45 | €62,575 | €23,550 | -€39,025 | -62.4% |
| Taxes | 450/3 | €62,575 | €23,550 | -€39,025 | -62.4% |
| Other amounts payable | 47/48 | €293,832 | €368,494 | +€74,661 | +25.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,365 | €169 | -€1,196 | -87.6% |
| Other operating charges | 640/8 | €387 | €0 | -€387 | -100% |
| Gross operating margin | 9900 | €222,141 | €210,207 | -€11,934 | -5.4% |
| Operating profit (loss) | 9901 | €220,388 | €210,038 | -€10,350 | -4.7% |
| Financial income | 75/76B | €0 | €15 | +€15 | +3,640% |
| Recurring financial income | 75 | €0 | €15 | +€15 | +3,640% |
| Financial charges | 65/66B | €51 | €127 | +€76 | +147% |
| Recurring financial charges | 65 | €51 | €127 | +€76 | +147% |
| Profit (loss) for the period before taxes | 9903 | €220,338 | €209,926 | -€10,411 | -4.7% |
| Income taxes | 67/77 | €55,435 | €52,991 | -€2,445 | -4.4% |
| Profit (loss) for the period | 9904 | €164,902 | €156,935 | -€7,967 | -4.8% |
| Profit (loss) for the period to be appropriated | 9905 | €164,902 | €156,935 | -€7,967 | -4.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.